Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AbbVie Hikes Doc Payments By 135%, Merck By 86% As BMS, J&J Cut Spending

Executive Summary

Under CMS' Open Payments program, medical product manufacturers reported $8.1bn in payments and ownership and investment interests to physicians and teaching hospitals in 2016, a 1% increase from the previous year.

You may also be interested in...



Novartis To Make Its Medical Education Programs Virtual Under DOJ Settlement

Two settlements totaling $729m resolve kickback claims related to speaker programs and copay charities; Novartis will limit payments to healthcare professionals for providing medical education under a new corporate integrity agreement.

Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be lasting problem.

GSK Payments To Physicians Dropped 33% In 2015; Most Firms Saw Boost

Under CMS' Open Payments program, medical product manufacturers reported $7.52bn in payments and ownership and investment interests to physicians and teaching hospitals, up from $6.49bn in 2014.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel